Masimo Announces FDA Clearance of Pediatric Indication for SedLine® Brain Function Monitoring and the SedLine Pediatric EEG Sensor
SedLine’s Advanced Depth of Anesthesia Monitoring Now Cleared for Use on Patients as Young as 1 Year Old in the...
Month: February 2022
Defence Releases Peer-Reviewed Publication of Its Preclinical Data on AccuVAC-D001L In Cell Reports Medicine Journal
Vancouver, British Columbia--(Newsfile Corp. - February 28, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
Enterprises Must Utilize Modern Communication Methods to Scale Fast, Says Kaleyra
Using up-to-the-minute messaging services, such as WhatsApp and video calling, is vital for businesses to grow their user base BARCELONA...
Kinetik Wellbeing working with NHS’s Monitor My Health to provide at-home blood test kits
Redhill, UK, 28th February 2022: Kinetik Wellbeing, the UK company helping people to take control of their health, has joined...
NHI Provides Update on Lawsuit Related to Legacy Holiday Properties
MURFREESBORO, TN / ACCESSWIRE / February 28, 2022 / National Health Investors, Inc. (NYSE:NHI) announced today that a hearing in...
Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment
Heidelberg Pharma grants Huadong exclusive license to develop and commercialize HDP-101 and HDP-103 in Asia (excluding Japan), plus exclusive opt-in...
Late-breaking data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly improved signs and symptoms of eosinophilic esophagitis
Late-breaking data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly improved signs and symptoms of eosinophilic esophagitis Dupixent 300...
Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria
Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with...
Lexicon Pharmaceuticals to Host Fourth Quarter 2021 Financial Results Conference Call and Webcast on February 28, 2022
THE WOODLANDS, Texas, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its fourth quarter 2021...
PacBio Grants Equity Incentive Award to New Employee
MENLO PARK, Calif., Feb. 25, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing...
Next Green Wave Shareholders Approve Acquisition by Planet 13
LAS VEGAS, NV / ACCESSWIRE / February 25, 2022 / Planet 13 Holdings Inc. ("Planet 13" or the "Company") (CSE:PLTH)...
Zomedica Announces Fourth Quarter and 2021 Revenues of $4.1 Million; 73.9% Gross Margin
ANN ARBOR, MI / ACCESSWIRE / February 25, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
POKO Nominated for 4 Awards at the OTC and Retail Pharmacy Product Awards
Poko also attends and builds industry connections at the Beauty Awards with ASOS in LondonNot for distribution to U.S. Newswire...
West Island Closes on 2nd Tranche of Private Placement
Toronto, Ontario--(Newsfile Corp. - February 25, 2022) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) ("West Island"...
Boosh Integrates Beanfields; Secures New Clients
Vancouver, British Columbia--(Newsfile Corp. - February 25, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or...
cbdMD Signs Multi-Year Partnership with INDYCAR driver and 7x NASCAR Champion Jimmie Johnson as Brand Ambassador
Charlotte, North Carolina--(Newsfile Corp. - February 25, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), (the "Company") one...
MediOrbis Announces Expanded Navigation and Assistance Programs: Specialty Telemedicine Programs to Now Also Include Enhanced Member Information and Guidance
MediOrbis TM Announces Expanded Navigation and Assistance Programs: Specialty Telemedicine Programs to Now Also Include Enhanced Member Information and Guidance...
NLS Pharmaceutics to Participate in the SACHS 15th Annual European Life Sciences Virtual CEO Forum and a Fireside Chat with Maxim Analyst in March
ZURICH, SWITZERLAND / ACCESSWIRE / February 25, 2022 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
9 Meters Biopharma Announces Publication of Data on Larazotide for the Treatment of Multisystem Inflammatory Syndrome in Children (MIS-C)
RALEIGH, NC / ACCESSWIRE / February 25, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments...
POINT Biopharma Announces Abstract Publication of Dosimetry Data Findings from the Lead-In Cohort of the SPLASH trial in mCRPC at the 2022 SNMMI Mid-Winter & ACNM Annual Meeting
Dosimetry data demonstrated PNT2002 has a favorable and safe dosimetry profile in the patient population and dose regimen being studied...